Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma
This study has been completed.
Study NCT00267046   Information provided by M.D. Anderson Cancer Center
First Received: December 19, 2005   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Oral Mucositis
Additional conditions recognized in this trial
Mucositis
Stomatitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Stomatognathic Diseases
Interventions listed in this trial
Palifermin
Placebo
Doxorubicin
Ifosfamide
Vincristine
Cisplatin
Additional drug interventions recognized in this trial
Isophosphamide mustard
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
M.D. Anderson Cancer Center
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services